20 research outputs found
68 ANTIVIRAL EFFICACY OF THE NS3 PROTEASE INHIBITOR, GS-9451, NON-NUCLEOSIDE NS5b INHIBITOR, TEGOBUVIR, AND PEGYLATED INTERFERON PLUS RIBAVIRIN IN TREATMENT-NAÏVE GENOTYPE 1 HEPATITIS C INFECTED PATIENTS
No full textTreatment with SOF/VEL is well tolerated and results in high SVR12 in genotype 1-6 HCV infected patients with minimal fibrosis: a retrospective analysis of the ASTRAL clinical studies
No full textA Case-Control Study of The Factors Associated With Spontaneous Resolution of Hepatitis C Viremia
No full textRecommended from our members
413 FIBROTEST (FT) VALUE INDEPENDENTLY PREDICTS EARLY (EVR) AND SUSTAINED VIROLOGICAL RESPONSE (SVR) IN NON-RESPONDER PATIENTS RE-TREATED WITH PEGYLATED INTERFERON ALFA-2B (PEG-2B) AND RIBAVIRIN IN EPIC3
No full text
Impact of pegintron maintenance therapy on biomarkers (fibrotest [FT]-actitest [AT]) in cirrhotic (METAVIR F$) HCV prior non-responders : results from the epic3 cirrhosis maintenance trial
No full text
Gene activation by the AraC protein can be inhibited by DNA looping between AraC and a LexA repressor that interacts with AraC: possible applications as a two-hybrid system
No full textIntracardiac right-to-left shunts demonstrated by two-dimensional echocardiography after peripheral vein injection.
No full textAttack preference of Ips pini on Pinus ponderosa in northern Arizona: tree size and bole position
No full text
